Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dickenmann

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2005
Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysisLaurence Vernez, Michael Dickenmann, Jürg Steiger, et al.
Swiss Medical Weekly|December 24, 2014
Prevalence and risk factors for chronic kidney disease in a rural region of HaitiFelix Burkhalter, Herriot Sannon, Michael Mayr, et al.
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Medication non adherence - predictive factors and diagnostics]Petra Schäfer-Keller, Daniela Garzoni, Michael Dickenmann, et al.
Transplantation|March 19, 2008
Urinary C4d does not correlate with C4d-staining in peritubular capillaries but reflects nonspecific glomerular injuryGideon Hönger, Michael Mayr, Michael Dickenmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2005
Marked erythrocyte microcytosis under primary immunosuppression with sirolimusMin-Jeong Kim, Michael Mayr, Martina Pechula, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Kidney Pathology after Hematologic Cell Transplantation-A Single-Center Observation Study of Indication Biopsies and AutopsiesMichael Girsberger, Jörg P Halter, Helmut Hopfer, et al.
Clinical Transplantation|September 13, 2008
Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patientsSascha Hess, Sabina De Geest, Klaus Halter, et al.
Swiss Medical Weekly|August 14, 2025
Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case reportLeonore Ingold, Michael Dickenmann, Thomas Menter, et al.
Transplantation|December 17, 2009
Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejectionTobias Oettl, Eugenia Zuliani, Ariana Gaspert, et al.
Hematological Oncology|January 23, 2016
Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signallingThomas Menter, Michael Dickenmann, Darius Juskevicius, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2005
Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysisLaurence Vernez, Michael Dickenmann, Jürg Steiger, et al.
Swiss Medical Weekly|December 24, 2014
Prevalence and risk factors for chronic kidney disease in a rural region of HaitiFelix Burkhalter, Herriot Sannon, Michael Mayr, et al.
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Medication non adherence - predictive factors and diagnostics]Petra Schäfer-Keller, Daniela Garzoni, Michael Dickenmann, et al.
Transplantation|March 19, 2008
Urinary C4d does not correlate with C4d-staining in peritubular capillaries but reflects nonspecific glomerular injuryGideon Hönger, Michael Mayr, Michael Dickenmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2005
Marked erythrocyte microcytosis under primary immunosuppression with sirolimusMin-Jeong Kim, Michael Mayr, Martina Pechula, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Kidney Pathology after Hematologic Cell Transplantation-A Single-Center Observation Study of Indication Biopsies and AutopsiesMichael Girsberger, Jörg P Halter, Helmut Hopfer, et al.
Clinical Transplantation|September 13, 2008
Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patientsSascha Hess, Sabina De Geest, Klaus Halter, et al.
Swiss Medical Weekly|August 14, 2025
Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case reportLeonore Ingold, Michael Dickenmann, Thomas Menter, et al.
Transplantation|December 17, 2009
Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejectionTobias Oettl, Eugenia Zuliani, Ariana Gaspert, et al.
Hematological Oncology|January 23, 2016
Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signallingThomas Menter, Michael Dickenmann, Darius Juskevicius, et al.
Pageof 11